Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Overview of attention for article published in Journal of Hepatology, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 8 X users
patent: 3 patents

guideline: 6 clinical guideline sources

Readers on

mendeley: 111 Mendeley

So far, Altmetric has seen 8 Guidelines that reference this research output.

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

Clinical guideline published by European Association for the Study of the Liver (EASL) on 17 Dec 2024

The European Association for the Study of the Liver (EASL) is dedicated to advancing hepatology through education, research, and advocacy. It provides clinical practice guidelines, supports healthcare professionals, and promotes initiatives to combat liver diseases across Europe.

Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)

Clinical guideline published by China Association of Gerontology and Geriatrics on 27 May 2024

The China Association of Gerontology and Geriatrics (CAGG) is a national, non-profit academic social organization in China focused on aging research, geriatric medicine, and services for older adults

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical guideline published by Korean Liver Cancer Association (KLCA) on 01 Oct 2022

The Korean Liver Cancer Association (KLCA) is dedicated to enhancing public health through liver cancer research and knowledge exchange. It aims to establish standard diagnostic and treatment guidelines while supporting innovative research and providing accurate information to its members and the public.

Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma

Clinical guideline published by Sociedad Argentina de Hepatología (SAHE) on 25 Jun 2020

The Sociedad Argentina de Hepatología (SAHE) is dedicated to advancing hepatology in Argentina through education, research, and clinical guidelines. It offers resources for professionals, including consensus guidelines, events, and tools to enhance patient care in liver diseases.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 4 additional posts.